Compare Vanguard Growth Index Fund ETF (VUG) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Growth Index Fund ETF vs 22nd Century Group Inc — how do they compare? Vanguard Growth Index Fund ETF trades at $88.87, while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Vanguard Growth Index Fund ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| VUG | XXII | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $90.29 | $801.00 |
52-Week Low | $70.00 | $3.72 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vanguard Growth ETF (VUG) trades at $88.87, down 0.35% today, with a bullish technical outlook supported by moving averages. The ETF shows strong institutional accumulation, with multiple firms increasing positions by over 500% in Q2 2026. Technical indicators show overbought RSI levels but strong trend momentum with ADX readings above 30.
VUG offers exposure to large-cap growth stocks with historical outperformance versus the S&P 500. Risks include growth stock volatility and concentration in technology sectors. The ETF remains attractive for long-term investors seeking growth exposure, though current overbought conditions suggest potential for near-term consolidation.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vanguard Growth Index Fund ETF
VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
